INS and type 2 diabetes mellitus: Abnormalities in the early phase of insulin secretion are early signs of insulin secretion defects in the progress of Type 2 diabetes mellitus (T2DM) and exist throughout the course of diabetes, which constitute the main cause of postprandial hyperglycemia that is an independent risk factor for all-cause death and fatal cardiovascular death (1–3).